CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Taikang Asset Management (Hong Kong) Co Ltd's Holding History (CIK: 0001755911)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 8,500 Value ($000) $285 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 8,500 Value ($000) $435 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 8,500 Value ($000) $434 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 8,500 Value ($000) $381 Avg Close $46.18 Range $41.01 - $53.70